Cash from Operations (Quarterly) Chart

View Cash from Operations (Quarterly) for HROW.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Operations (Quarterly) Chart
Start Trial

Historical Cash from Operations (Quarterly) Data

View and export this data back to 2007. Start Trial.
Date Value
June 30, 2026 -9.755M
March 31, 2026 -8.992M
December 31, 2025 8.411M
September 30, 2025 16.59M
June 30, 2025 -0.803M
March 31, 2025 19.67M
December 31, 2024 -17.78M
September 30, 2024 2.951M
June 30, 2024 -2.746M
March 31, 2024 -4.628M
December 31, 2023 8.696M
September 30, 2023 -1.208M
June 30, 2023 4.566M
March 31, 2023 -8.214M
December 31, 2022 -3.712M
September 30, 2022 -0.41M
June 30, 2022 4.86M
March 31, 2022 0.967M
December 31, 2021 -1.49M
September 30, 2021 -2.076M
June 30, 2021 5.44M
March 31, 2021 3.208M
December 31, 2020 -0.566M
September 30, 2020 2.667M
June 30, 2020 -2.651M
Date Value
March 31, 2020 -0.55M
December 31, 2019 1.652M
September 30, 2019 -0.07M
June 30, 2019 0.844M
March 31, 2019 -1.476M
December 31, 2018 -0.036M
September 30, 2018 0.323M
June 30, 2018 1.365M
March 31, 2018 -0.965M
December 31, 2017 -0.294M
September 30, 2017 -2.224M
June 30, 2017 -2.305M
March 31, 2017 -3.98M
December 31, 2016 -2.238M
September 30, 2016 -3.909M
June 30, 2016 -2.767M
March 31, 2016 -2.301M
December 31, 2015 -3.301M
September 30, 2015 -2.395M
June 30, 2015 -3.172M
March 31, 2015 -2.275M
December 31, 2014 -2.051M
September 30, 2014 -1.795M
June 30, 2014 -1.532M
March 31, 2014 -1.676M

Cash From Operations Definition

Represents the net cash flow from the company's business operations.

Read full definition.

Cash from Operations (Quarterly) Range, Past 5 Years

View Cash from Operations (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Operations (Quarterly) Benchmarks

View Cash from Operations (Quarterly) Benchmarks
Start Trial
Viatris, Inc. 381.80M
Zevra Therapeutics, Inc. 17.03M
Indivior Pharmaceuticals, Inc. 228.52M
Liquidia Corp. 80.24M
60 Degrees Pharmaceuticals, Inc. -2.232M